Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | KU-55933 |
| Synonyms | |
| Therapy Description |
KU-55933 inhibits ATM, resulting in decreased activation of ATM targets and increased sensitivity of tumor cells to DNA damaging agents (PMID: 15604286, PMID: 31299316). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| KU-55933 | KU55933 | ATM Inhibitor 13 | KU-55933 inhibits ATM, resulting in decreased activation of ATM targets and increased sensitivity of tumor cells to DNA damaging agents (PMID: 15604286, PMID: 31299316). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| PTEN loss | colon cancer | sensitive | KU-55933 | Preclinical | Actionable | In a preclinical study, KU-55933 induced cell cycle arrest and caspase activation in PTEN deficient human colon cancer cells in culture (PMID: 25870146). | 25870146 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|